CN106728993A - A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method - Google Patents
A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method Download PDFInfo
- Publication number
- CN106728993A CN106728993A CN201510820296.6A CN201510820296A CN106728993A CN 106728993 A CN106728993 A CN 106728993A CN 201510820296 A CN201510820296 A CN 201510820296A CN 106728993 A CN106728993 A CN 106728993A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- tranquilization
- lozenge
- nourishing blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000246868 Astilbe japonica Species 0.000 title claims abstract description 30
- 239000007937 lozenge Substances 0.000 title claims abstract description 26
- 239000008280 blood Substances 0.000 title claims abstract description 23
- 210000004369 blood Anatomy 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 13
- 239000003826 tablet Substances 0.000 claims abstract description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims abstract description 19
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 claims abstract description 19
- 239000008103 glucose Substances 0.000 claims abstract description 19
- 239000008107 starch Substances 0.000 claims abstract description 19
- 235000019698 starch Nutrition 0.000 claims abstract description 19
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 14
- 241000218378 Magnolia Species 0.000 claims abstract description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 14
- 244000178320 Vaccaria pyramidata Species 0.000 claims abstract description 14
- 235000010587 Vaccaria pyramidata Nutrition 0.000 claims abstract description 14
- 240000008042 Zea mays Species 0.000 claims abstract description 14
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 14
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 14
- 235000005822 corn Nutrition 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 13
- 238000001035 drying Methods 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 7
- 238000004806 packaging method and process Methods 0.000 claims abstract description 7
- 241000218236 Cannabis Species 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 3
- -1 packaging Substances 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 235000014347 soups Nutrition 0.000 claims description 3
- 238000001694 spray drying Methods 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims 2
- 239000003814 drug Substances 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000001228 trophic effect Effects 0.000 abstract description 2
- 240000004308 marijuana Species 0.000 abstract 1
- 206010011224 Cough Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 208000024794 sputum Diseases 0.000 description 4
- 210000003802 sputum Anatomy 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method.By willowleaf spiraea herb and root, peach kernel, Longstamen Onion Bulb, corn stigma, the bark of official magnolia, fructus cannabis, Exocarpium Citri Grandis, the seed of cowherb, carboxymethylcellulose calcium,
Water soluble starch,
Glucose
Constituted Deng raw material, finished product is made by sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging.
Active ingredient in Chinese medicine is decocted and is made extract solution by the present invention, active ingredient is combined with lozenge, the nutriment in the Chinese medicine being effectively kept；By the proportioning of science, when product of the present invention is nourished human body, with mending without dry, trophic structure rationally, strengthens effect of human body constitution.The present invention
Have
Health care, nourishing blood and tranquilization, pure natural, pollution-free, no side effectses, the advantages of conveniently take and nourish the body.
Description
Technical field：
The present invention relates to field of food health care, and in particular to a kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method.
Background technology
Buccal tablet refers to the compressed tablets for being contained in slow mechanism dissolved in oral cavity, and lozenge will have tempting color from inside to outside, so that the mouthfeel that user has had.Therefore, the figuration composition in lozenge, such as sugar, pigment additive often " a presumptuous guest usurps the role of the host " so that some by mistake lozenge is regarded as " sugar ".
At present, most of lozenge of in the market is all medicine, and most of medicines for being to treat Throat diseases, and narrow application range, therapeutic effect is general.And it is few using the utilization rate for being processed into health products containing chip technology, it is few to body-care effect, it is impossible to meet the market demand.
The content of the invention：
It is an object of the invention to provide one kind collection nourishing blood and tranquilization, it is pure natural, pollution-free,
No side effectses are conveniently taken and are nourished the body in one
Willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and production method.
The object of the present invention is achieved like this.It is that the raw material matched somebody with somebody by following weight is made,
Willowleaf spiraea herb and root
15-30
Part, peach kernel
10-20
Part, Longstamen Onion Bulb
5-15
Part, corn stigma
3-15
Part, the bark of official magnolia
3-15
Part, fructus cannabis
3-10
Part, Exocarpium Citri Grandis
4-12
Part, the seed of cowherb
6-9
Part, carboxymethylcellulose calcium
7-10
Part, water soluble starch
4-8
Part, glucose
10-15
Part.
Preparing willowleaf spiraea herb and root nourishing blood and tranquilization lozenge preferred weight ratio range of the present invention is,
Willowleaf spiraea herb and root
15-25
Part, peach kernel
10-15
Part, Longstamen Onion Bulb
5-12
Part, corn stigma
3-10
Part, the bark of official magnolia
3-10
Part, fructus cannabis
3-8
Part, Exocarpium Citri Grandis
4-10
Part, the seed of cowherb
6-8
Part, carboxymethylcellulose calcium
7-9
Part, water soluble starch
4-7
Part, glucose
10-14
Part.
Preparing willowleaf spiraea herb and root nourishing blood and tranquilization lozenge best weight ratio scope of the present invention is,
Willowleaf spiraea herb and root
20
Part, peach kernel
12
Part, Longstamen Onion Bulb
10
Part, corn stigma
8
Part, the bark of official magnolia
8
Part, fructus cannabis
5
Part, Exocarpium Citri Grandis
8
Part, the seed of cowherb
7
Part, carboxymethylcellulose calcium
8
Part, water soluble starch
6
Part, glucose
12
Part.
Above-mentioned each component is made the production method of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge of the present invention, technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A
, sorting, by raw material weight proportioning of soup processed, select meet the willowleaf spiraea herb and root of national health and quality standard, peach kernel, Longstamen Onion Bulb, corn stigma, the bark of official magnolia, fructus cannabis, Exocarpium Citri Grandis, the seed of cowherb, carboxymethylcellulose calcium,
Water soluble starch,
Glucose feed is standby；
B
, drying, except carboxymethylcellulose calcium,
Water soluble starch,
Outside glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control exists
80-100
DEG C, the time
45
Minute, raw material moisture is evaporated to water content
18%
, compressing tablet；
C
, decoct, by above-mentioned ratio of weight and number, decocted during the raw material addition after drying is put into decocting device
2
It is secondary, add for the first time
7
Times water is decocted
1.5
Hour, second frame
5
Times water is decocted
1
Hour, filtrate is extracted in filtering respectively, will filtrate merging twice, the secondary filter dregs of a decoction and impurity, prepared extract solution；
D
, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E
, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F
, compressing tablet, by above-mentioned mixed powder remove production process in generation impurity, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G
, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
With lozenge be combined the traditional Chinese medicine ingredients for having good tonic effect to human body by the present invention, there is more preferable assimilation effect compared to existing lozenge, it is convenient for people to usually take, conditioning health, increase metabolism balance in vivo, regulation human body homeostasis is softer, and lifting constitution is gentler, effective for a long time can increase human body power and work endurance.
Active ingredient in Chinese medicine is decocted and is made extract solution by the present invention, active ingredient is combined with lozenge, the nutriment in the Chinese medicine being effectively kept；By the proportioning of science, when product of the present invention is nourished human body, with mending without dry, trophic structure rationally, strengthens effect of human body constitution.
In inventive formulation, willowleaf spiraea herb and root nourishing blood and tranquilization, sharp water defaecation, nourishing blood and tranquilization, main traumatic injury, joint pain, amenorrhoea, dysmenorrhoea, difficult urination, constipation, coughing with a lot of sputum；Peach kernel promoting blood circulation, relaxes bowel；For Amenorrhea, dysmenorrhoea , wei lump in the abdomen lump in the abdomens, injury from falling down, dry constipation of intestines；
Longstamen Onion Bulb activates yang and remove abstruction, and promoting the circulation of qi is led stagnant；For obstruction of qi in the chest pain, phlegm and retained fluid cough and asthma lets out weight after dysentery；Corn stigma is mild-natured, slightly sweet flavor, nontoxic；Enter liver, kidney, bladder warp.Diuresis, expels the heat-evil, soothing the liver, cholagogic.Control nephritic dropsy, tinea pedis, icterohepatitis, hypertension, cholecystitis, gall stone, diabetes, hematemesis and epistaxis, nasosinusitis, acute mastitis；Bark of official magnolia eliminating dampness dissolving phlegm, lower gas removes full；For in humidity hysteresis wound, gastral cavity ruffian is vomited and diarrhoea, stagnation of QI due to dyspepsia, abdominal distention constipation, phlegm and retained fluid is breathed with cough；Fructus cannabis is clearing heat and detoxicating, cool blood relieving sore-throat；For febrile virulent maculae, tongue is dark reddish purple dark, mumps, larynx numbness, scarlet fever, major part pestilence, erysipelas, carbuncle swells；Exocarpium Citri Grandis resolving sputum, qi-regulating, stomach invigorating helps digestion；Control phlegm in the heart stagnant, cough and asthma vomits hiccup, eating accumulation；
Seed of cowherb invigorate blood circulation, lower breast detumescence；For agalactia, Amenorrhea, dysmenorrhoea, acute mastitis swells and ache
。
The present invention is summarized and perfect in taking and clinical verification by many cases patient, constantly, and recipe ratio is more complete, determined curative effect, to traumatic injury, joint pain
Deng master
Disease
Card：Degree difference is served
Nourishing blood and tranquilization, sharp water defaecation
Effect,
Have
The advantages of health care, nourishing blood and tranquilization, pure natural, pollution-free, no side effectses.
The present invention through two groups of clinical verifications, for treatment group take lozenge of the present invention, take once a day by one of which, and 7 days is a course for the treatment of, and " Anshen Bunao mixture " is taken in another group of control,
Take once a day, be within 7 days a course for the treatment of, every group selection outpatient 200, wherein man 100, female 100, measure the big age 77
It is year, minimum
Age 22
Year,
Clinical manifestation is traumatic injury, joint pain, difficult urination, constipation, coughing with a lot of sputum
, obstruction of qi in the chest pain, phlegm and retained fluid cough and asthma lets out weight after dysentery
,
Nephritic dropsy, tinea pedis
, table one is to take the contrasting data after a course for the treatment of：
Table
1
Front and rear two groups of courses for the treatment of are taken to compare
(
Unit
:
People
)
There were significant differences for treatment group and control group, it will thus be seen that present invention application clinically has significant curative effect.
Technological advantage of the invention is：1st, raw material and scientific formulation are selected, production technology is advanced, its product produces taste well, convenient storage；2nd, without harmful components such as preservatives in product, nourishing and nutrition of the raw material to human body are kept, is easily absorbed by the body；3rd, raw material sources are extensive, plus process line is short, the manufacture of product easy processing.
Specific embodiment
With reference to specific embodiment, the present invention is further illustrated
Embodiment 1：Suitable for traumatic injury, joint pain, difficult urination
Crowd
Willowleaf spiraea herb and root nourishing blood and tranquilization lozenge of the present invention is prepared to be made up of following component raw material（Consumption is weight portion）,
Willowleaf spiraea herb and root
15-30
Part, peach kernel
10-20
Part, Longstamen Onion Bulb
5-15
Part, corn stigma
3-15
Part, the bark of official magnolia
3-15
Part, fructus cannabis
3-10
Part, Exocarpium Citri Grandis
4-12
Part, the seed of cowherb
6-9
Part, carboxymethylcellulose calcium
7-10
Part, water soluble starch
4-8
Part, glucose
10-15
Part.
Embodiment 2：Suitable for constipation, coughing with a lot of sputum
, obstruction of qi in the chest pain, phlegm and retained fluid cough and asthma
Crowd
Preparing willowleaf spiraea herb and root nourishing blood and tranquilization lozenge preferred weight ratio range of the present invention is：
Willowleaf spiraea herb and root
15-25
Part, peach kernel
10-15
Part, Longstamen Onion Bulb
5-12
Part, corn stigma
3-10
Part, the bark of official magnolia
3-10
Part, fructus cannabis
3-8
Part, Exocarpium Citri Grandis
4-10
Part, the seed of cowherb
6-8
Part, carboxymethylcellulose calcium
7-9
Part, water soluble starch
4-7
Part, glucose
10-14
Part.
Embodiment
3
：It is applied to
Let out weight after dysentery
,
Nephritic dropsy, tinea pedis
Crowd
Preparing willowleaf spiraea herb and root nourishing blood and tranquilization lozenge best weight ratio scope of the present invention is, 20 parts of willowleaf spiraea herb and root, 12 parts of peach kernel, 10 parts of Longstamen Onion Bulb, 8 parts of corn stigma, 8 parts of the bark of official magnolia, 5 parts of fructus cannabis, 8 parts of Exocarpium Citri Grandis, 7 parts of the seed of cowherb, 8 parts of carboxymethylcellulose calcium, 6 parts of water soluble starch, 12 parts of glucose.
Embodiment 4
Above-mentioned each component is made the production method of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge of the present invention, technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A
, sorting, by raw material weight proportioning of soup processed, select meet the willowleaf spiraea herb and root of national health and quality standard, peach kernel, Longstamen Onion Bulb, corn stigma, the bark of official magnolia, fructus cannabis, Exocarpium Citri Grandis, the seed of cowherb, carboxymethylcellulose calcium,
Water soluble starch,
Glucose feed is standby；
B
, drying, except carboxymethylcellulose calcium,
Water soluble starch,
Outside glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control exists
80-100
DEG C, the time
45
Minute, raw material moisture is evaporated to water content
18%
, compressing tablet；
C
, decoct, by above-mentioned ratio of weight and number, decocted during the raw material addition after drying is put into decocting device
2
It is secondary, add for the first time
7
Times water is decocted
1.5
Hour, second frame
5
Times water is decocted
1
Hour, filtrate is extracted in filtering respectively, will filtrate merging twice, the secondary filter dregs of a decoction and impurity, prepared extract solution；
D
, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E
, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F
, compressing tablet, by above-mentioned mixed powder remove production process in generation impurity, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G
, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
Embodiment
2
If adding appropriate disintegrant such as in the prescription of lozenge
CMS-Na
Improve and contain tablet stability, or add the mediation mouthfeel such as cane sugar powder, mannitol, sorbierite, various sweeteners, essence.
Claims (4)
1. a kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge, it is characterised in that：It is that the raw material matched by following weight is made, willowleaf spiraea herb and root 15-30 parts, peach kernel 10-20 parts, Longstamen Onion Bulb 5-15 parts, corn stigma 3-15 parts, bark of official magnolia 3-15 parts, fructus cannabis 3-10 parts, Exocarpium Citri Grandis 4-12 parts, seed of cowherb 6-9 parts, carboxymethylcellulose calcium 7-10 parts, water soluble starch 4-8 parts, glucose 10-15 parts.
2. a kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge according to claim 1, it is characterised in that：The weight proportion of wherein various raw materials is, willowleaf spiraea herb and root 15-25 parts, peach kernel 10-15 parts, Longstamen Onion Bulb 5-12 parts, corn stigma 3-10 parts, bark of official magnolia 3-10 parts, fructus cannabis 3-8 parts, Exocarpium Citri Grandis 4-10 parts, seed of cowherb 6-8 parts, carboxymethylcellulose calcium 7-9 parts, water soluble starch 4-7 parts, glucose 10-14 parts.
3. a kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge according to claim 1, it is characterised in that：The weight proportion of wherein various raw materials is, 20 parts of willowleaf spiraea herb and root, 12 parts of peach kernel, 10 parts of Longstamen Onion Bulb, 8 parts of corn stigma, 8 parts of the bark of official magnolia, 5 parts of fructus cannabis, 8 parts of Exocarpium Citri Grandis, 7 parts of the seed of cowherb, 8 parts of carboxymethylcellulose calcium, 6 parts of water soluble starch, 12 parts of glucose.
4. the production method of the willowleaf spiraea herb and root nourishing blood and tranquilization lozenge according to claim 1-3, it is characterised in that：Technical process is：Sorting, drying, decoction, mixing, powder processed, compressing tablet, packaging, concrete operation method follow these steps to successively：
A, sorting, by raw material weight proportioning of soup processed, select that to meet the willowleaf spiraea herb and root of national health and quality standard, peach kernel, Longstamen Onion Bulb, corn stigma, the bark of official magnolia, fructus cannabis, Exocarpium Citri Grandis, the seed of cowherb, carboxymethylcellulose calcium, water soluble starch, glucose feed standby；
B, drying, in addition to carboxymethylcellulose calcium, water soluble starch, glucose, other raw materials are cut into block or sheet and are placed in desiccation in drying baker respectively, and temperature control 45 minutes time, makes raw material moisture be evaporated to water content 18%, compressing tablet at 80-100 DEG C；
C, decoction, by above-mentioned ratio of weight and number, decocted 2 times during the raw material addition after drying is put into decocting device, for the first time plus 7 times of waters are decocted 1.5 hours, second frame, 5 times of waters are decocted 1 hour, and filtrate is extracted in filtering respectively, filtrate will be merged twice, the secondary filter dregs of a decoction and impurity, are obtained extract solution；
D, mixing, by above-mentioned ratio of weight and number, carboxymethylcellulose calcium, water soluble starch, glucose will be added to be sufficiently mixed uniformly in extract solution, prepared mixed liquor；
E, powder processed, the filtrate of above-mentioned mixed liquor is cooled to room temperature, filtrate is made mixed powder using spray drying process, it is standby；
F, compressing tablet, the impurity that above-mentioned mixed powder is removed the generation in production process, then using the mode and ultraviolet compressing tablet mode compressing tablet for radiating compressing tablet；Tablet press machine direct tablet compressing is utilized after compressing tablet；
G, packaging, by the good tablet of above-mentioned pressing according to specification for sale pack.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510820296.6A CN106728993A (en) | 2015-11-24 | 2015-11-24 | A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510820296.6A CN106728993A (en) | 2015-11-24 | 2015-11-24 | A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106728993A true CN106728993A (en) | 2017-05-31 |
Family
ID=58963294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510820296.6A Pending CN106728993A (en) | 2015-11-24 | 2015-11-24 | A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106728993A (en) |
-
2015
- 2015-11-24 CN CN201510820296.6A patent/CN106728993A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106728993A (en) | A kind of willowleaf spiraea herb and root nourishing blood and tranquilization lozenge and its production method | |
| CN106728997A (en) | A kind of eleusine indica heat-clearing lozenge and its production method | |
| CN106722898A (en) | A kind of Fructus Corni tonifies the liver and kidney lozenge and its production method | |
| CN106728854A (en) | One kind the thorn clearing heat and detoxicating lozenge of spinach and its production method | |
| CN106729171A (en) | A kind of barley strengthening the spleen and stomach lozenge and its production method | |
| CN106728111A (en) | A kind of calabash blood-stasis-dissipating blood-circulation-promoting lozenge and its production method | |
| CN106722904A (en) | A kind of shrub lespedeza moistening lung and clearing heat lozenge and its production method | |
| CN106729488A (en) | A kind of duckweed dispelling wind-heat lozenge and its production method | |
| CN106729269A (en) | A kind of Galanga Galangal Seed is amusing lozenge and its production method of helping digestion | |
| CN106728560A (en) | A kind of white mountain azalea and blood lozenge and its production method | |
| CN106729293A (en) | A kind of clearing heat and detoxicating lozenge of mung bean and its production method | |
| CN106722977A (en) | A kind of strong muscle improving eyesight lozenge of vaccini,fructus and its production method | |
| CN106722906A (en) | A kind of setose thistle eliminating stasis to resolve swelling lozenge and its production method | |
| CN106728995A (en) | A kind of potentilla chinensis wind-damp dispelling lozenge and its production method | |
| CN106722899A (en) | A kind of drying damp and strengthening spleen lozenge of rhizoma atractylodis and its production method | |
| CN106728463A (en) | A kind of cloves temperature taste lozenge and its production method | |
| CN106722908A (en) | A kind of promoting blood circulation lozenge of akebi and its production method | |
| CN106729197A (en) | A kind of Smilax china L removing toxicity for eliminating carbuncles lozenge and its production method | |
| CN106722900A (en) | A kind of malt helps digestion and middle lozenge and its production method | |
| CN106728499A (en) | A kind of winter creeper is stimulated the circulation of the blood and cause the muscles and joints to relax lozenge and its production method | |
| CN106722905A (en) | A kind of Flos clerodendri japonici is calmed the nerves lozenge and its production method | |
| CN106728183A (en) | A kind of walnut kernel temperature compensation kidney lung lozenge and its production method | |
| CN106728443A (en) | A kind of sharpfruit calanthodes herb dispelling wind and eliminating dampness lozenge and its production method | |
| CN106728932A (en) | A kind of juice of Japanese banana heat-clearing lozenge and its production method | |
| CN106728559A (en) | A kind of pawpaw suppressing the hyperactive liver and easing the stomach lozenge and its production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20181116 Address after: 150046 Junmin Street, Xiangfang District, Harbin City, Heilongjiang Province, 24 Lihui Green Town, B5 Building, Unit 2, Unit 8, Unit 1 Applicant after: HARBIN MOYI BIOTECHNOLOGY CO., LTD. Applicant after: Heilongjiang Dabeiqing Biopharmaceutical Co., Ltd. Address before: 150046 Junmin Street, Xiangfang District, Harbin City, Heilongjiang Province, 24 Lihui Green Town, B5 Building, Unit 2, Unit 8, Unit 1 Applicant before: HARBIN MOYI BIOTECHNOLOGY CO., LTD. |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |